Identification of combinatorial drug regimens for treatment of Huntington's disease using Drosophila

Namita Agrawal, Judit Pallos, Natalia Slepko, Barbara L. Apostol, L. Bodai, Ling Wen Chang, Ann Shyn Chiang, Leslie Michels Thompson, J. Lawrence Marsh

Research output: Contribution to journalArticle

121 Citations (Scopus)

Abstract

We explore the hypothesis that pathology of Huntington's disease involves multiple cellular mechanisms whose contributions to disease are incrementally additive or synergistic. We provide evidence that the photoreceptor neuron degeneration seen in flies expressing mutant human huntingtin correlates with widespread degenerative events in the Drosophila CNS. We use a Drosophila Huntington's disease model to establish dose regimens and protocols to assess the effectiveness of drug combinations used at low threshold concentrations. These proof of principle studies identify at least two potential combinatorial treatment options and illustrate a rapid and cost-effective paradigm for testing and optimizing combinatorial drug therapies while reducing side effects for patients with neurodegenerative disease. The potential for using prescreening in Drosophila to inform combinatorial therapies that are most likely to be effective for testing in mammals is discussed.

Original languageEnglish
Pages (from-to)3777-3781
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume102
Issue number10
DOIs
Publication statusPublished - Mar 8 2005

Fingerprint

Huntington Disease
Drosophila
Pharmaceutical Preparations
Nerve Degeneration
Drug Combinations
Diptera
Neurodegenerative Diseases
Mammals
Therapeutics
Pathology
Costs and Cost Analysis
Drug Therapy

Keywords

  • Combinatorial treatments
  • Neurodegeneration

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Identification of combinatorial drug regimens for treatment of Huntington's disease using Drosophila. / Agrawal, Namita; Pallos, Judit; Slepko, Natalia; Apostol, Barbara L.; Bodai, L.; Chang, Ling Wen; Chiang, Ann Shyn; Thompson, Leslie Michels; Marsh, J. Lawrence.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 102, No. 10, 08.03.2005, p. 3777-3781.

Research output: Contribution to journalArticle

Agrawal, Namita ; Pallos, Judit ; Slepko, Natalia ; Apostol, Barbara L. ; Bodai, L. ; Chang, Ling Wen ; Chiang, Ann Shyn ; Thompson, Leslie Michels ; Marsh, J. Lawrence. / Identification of combinatorial drug regimens for treatment of Huntington's disease using Drosophila. In: Proceedings of the National Academy of Sciences of the United States of America. 2005 ; Vol. 102, No. 10. pp. 3777-3781.
@article{545d5d2d504d4fccac6eccaf63be17f7,
title = "Identification of combinatorial drug regimens for treatment of Huntington's disease using Drosophila",
abstract = "We explore the hypothesis that pathology of Huntington's disease involves multiple cellular mechanisms whose contributions to disease are incrementally additive or synergistic. We provide evidence that the photoreceptor neuron degeneration seen in flies expressing mutant human huntingtin correlates with widespread degenerative events in the Drosophila CNS. We use a Drosophila Huntington's disease model to establish dose regimens and protocols to assess the effectiveness of drug combinations used at low threshold concentrations. These proof of principle studies identify at least two potential combinatorial treatment options and illustrate a rapid and cost-effective paradigm for testing and optimizing combinatorial drug therapies while reducing side effects for patients with neurodegenerative disease. The potential for using prescreening in Drosophila to inform combinatorial therapies that are most likely to be effective for testing in mammals is discussed.",
keywords = "Combinatorial treatments, Neurodegeneration",
author = "Namita Agrawal and Judit Pallos and Natalia Slepko and Apostol, {Barbara L.} and L. Bodai and Chang, {Ling Wen} and Chiang, {Ann Shyn} and Thompson, {Leslie Michels} and Marsh, {J. Lawrence}",
year = "2005",
month = "3",
day = "8",
doi = "10.1073/pnas.0500055102",
language = "English",
volume = "102",
pages = "3777--3781",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "10",

}

TY - JOUR

T1 - Identification of combinatorial drug regimens for treatment of Huntington's disease using Drosophila

AU - Agrawal, Namita

AU - Pallos, Judit

AU - Slepko, Natalia

AU - Apostol, Barbara L.

AU - Bodai, L.

AU - Chang, Ling Wen

AU - Chiang, Ann Shyn

AU - Thompson, Leslie Michels

AU - Marsh, J. Lawrence

PY - 2005/3/8

Y1 - 2005/3/8

N2 - We explore the hypothesis that pathology of Huntington's disease involves multiple cellular mechanisms whose contributions to disease are incrementally additive or synergistic. We provide evidence that the photoreceptor neuron degeneration seen in flies expressing mutant human huntingtin correlates with widespread degenerative events in the Drosophila CNS. We use a Drosophila Huntington's disease model to establish dose regimens and protocols to assess the effectiveness of drug combinations used at low threshold concentrations. These proof of principle studies identify at least two potential combinatorial treatment options and illustrate a rapid and cost-effective paradigm for testing and optimizing combinatorial drug therapies while reducing side effects for patients with neurodegenerative disease. The potential for using prescreening in Drosophila to inform combinatorial therapies that are most likely to be effective for testing in mammals is discussed.

AB - We explore the hypothesis that pathology of Huntington's disease involves multiple cellular mechanisms whose contributions to disease are incrementally additive or synergistic. We provide evidence that the photoreceptor neuron degeneration seen in flies expressing mutant human huntingtin correlates with widespread degenerative events in the Drosophila CNS. We use a Drosophila Huntington's disease model to establish dose regimens and protocols to assess the effectiveness of drug combinations used at low threshold concentrations. These proof of principle studies identify at least two potential combinatorial treatment options and illustrate a rapid and cost-effective paradigm for testing and optimizing combinatorial drug therapies while reducing side effects for patients with neurodegenerative disease. The potential for using prescreening in Drosophila to inform combinatorial therapies that are most likely to be effective for testing in mammals is discussed.

KW - Combinatorial treatments

KW - Neurodegeneration

UR - http://www.scopus.com/inward/record.url?scp=14844341251&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14844341251&partnerID=8YFLogxK

U2 - 10.1073/pnas.0500055102

DO - 10.1073/pnas.0500055102

M3 - Article

VL - 102

SP - 3777

EP - 3781

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 10

ER -